CytomX Therapeutics, Inc. (CTMX)

3.865 -0.12 (-2.89%) USD  |  NASDAQ  |  May 11, 16:00
3.865 0.00 (0.00%) After-Hours: 17:34
More

CytomX Therapeutics Stock Based Compensation (TTM)

Stock Based Compensation (TTM) Chart

View Stock Based Compensation (TTM) for CTMX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (TTM) Range, Past 5 Years

View Stock Based Compensation (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (TTM) Benchmarks

View Stock Based Compensation (TTM) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Rigel Pharmaceuticals, Inc. Upgrade
Ovid Therapeutics, Inc. Upgrade
Gossamer Bio, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade